Jaime is a freelance writer for The American Journal of Managed Care® (AJMC®), where she previously worked as an assistant editor.
She has a BA in print journalism from Penn State University. You can connect with Jaime on LinkedIn.
Study Findings Signal Some PE-Backed Dermatology Practices May Not Be Performing WellMarch 18th 2022
Public financial statements from 9 dermatology groups backed by private equity (PE) were analyzed by the researchers, who described a significant decrease in debt valuations of these groups both before and during the COVID-19 pandemic.
Researchers Outline Management Strategies for Growing Adult SMA PopulationMarch 12th 2022
Due to advances in the treatment of spinal muscular atrophy (SMA), the lifespan of patients with the disease has increased significantly, allowing them to enter adulthood. However, the change in SMA prognosis has also led to a knowledge gap in the natural history, management, and treatment strategy for adult patients, according to the researchers.
PEF May Be Preferred Measure of Respiratory Strength for SMA Follow-UpMarch 4th 2022
With clear differences at baseline and subsequent declines seen in a linear pattern, the researchers suggested peak expiratory flow may be a suitable outcome measure for longitudinal assessment of respiratory muscle strength in these patients.
Dose Reduction May Lower Hair Loss Frequency, Allow for Longer Use of Isotretinoin for AcneMarch 4th 2022
Data from 22 studies were collected on reported hair loss with isotretinoin treatment, showing a hair loss frequency of 3.2% for patients receiving <0.5 mg/kg/day and a frequency of 5.7% for patients receiving ≥0.5 mg/kg/day.
Novel Scoring System Shows Promise in Assessing Severity of IchthyosisFebruary 26th 2022
The researchers concluded the system will be able to have a significant impact for both clinical use and research, allow for a more accurate assessment of disease burden, and better decision making and monitoring.
Researchers Offer Comprehensive Look at Rosacea Treatment OptionsFebruary 12th 2022
Affecting up to 1 in 10 people worldwide, rosacea has a complex pathophysiology that remains inadequately understood, and research has hinted at multiple inflammatory and immune mediated processes underlying the condition.
Researchers Determine What Patients, Caregivers Deem Meaningful Change in SMA Motor FunctionFebruary 12th 2022
Through the use of patient testimonials as well as analysis of data from a study of patients with spinal muscular atrophy (SMA), researchers were able to describe patient-centered “meaningful outcomes” in the 32-item Motor Function Measure.
Risdiplam May Be Superior for Certain SMA Type, According to Indirect ComparisonJanuary 30th 2022
Researchers compiled data from studies of oral Evrysdi (risdiplam), Spinraza (nusinersen), and Zolgensma (onasemnogene abeparvovec), finding evidence that risdiplam may be a favorable alternative to nusinersen for type 1 SMA.